A Prospective Observational Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Driver Genes
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 750
- 试验地点
- 1
- 主要终点
- Differences in overall survival rates
研究概览
简要总结
A single-center, non-interventional prospective observational study in the NSCLC patients with different driver genes
详细描述
The trial was designed as a single-center non-interventional prospective observational study to explore clinical treatments of the NSCLC patients with different driver genes, the impact factors of patient survivals, and the relevance of gene types, clinical treatments, and distribution of gene types. The follow-up visits, interactions between the investigators and patients, patient questionnaires/quality of life, and other patient information will be uploaded via mobile APP, and webchat every three months.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The patients with lung cancer who were performed with next-generation sequencing (NGS) technology from 2015 to 2017;
- •The patients who were at least 18 years;
- •The pathologically diagnosed patients with non-small cell lung cancer (NSCLC)
排除标准
- 未提供
结局指标
主要结局
Differences in overall survival rates
时间窗: 2018-2022
Differences in overall survival rates of the NSCLC patients with various gene types
次要结局
- Relevance of gene types(2018-2022)
- Interaction impact between gene types and treatment modalities or regimens on disease-free survivals(2018-2022)
- Impacts of progression-free survivals(2018-2022)
- Statuses of clinical treatment regimens(2018-2022)
- Impacts of disease-free survivals on gene types(2018-2022)
- Relevance of overall survival rates and gene types(2018-2022)
- Impact factors of overall survivals(2018-2022)
研究者
Jianxing He
Professor
The First Affiliated Hospital of Guangzhou Medical University